ADVERTISEMENT

Pembrolizumab improves metastasis-free survival in melanoma patients

Heather Mason   |   Medical News   |   24 October 2022
ADVERTISEMENT

Patients with melanoma with surgically removed cancer still have a high risk of disease recurrence. Intravenous pembrolizumab treatment improves recurrence-free and distant metastasis-free survival in patients with stage IIB or IIC melanoma, according to new research.

In this clinical trial, 976 patients were randomly assigned to receive pembrolizumab (n=487) or...

          

January Challenge

Ends in 2d 15h
left
right

Topic Challenges

left
right